← FDA DRUG APPROVALS

FDA BLA · BLA761530

LUMVOA

veligrotug

Sponsor: VIRIDIAN THERAPEUTICS INC

APPLICATION
BLA761530
TYPE
BLA
ORIGINAL APPROVAL
2026-06-26
LATEST ACTION
2026-06-26
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription

Products

LUMVOAPrescription
VELIGROTUG-VVZE 500MG/10ML · INJECTION

Approval history

2026-06-26Type 1 - New Molecular Entity · Original · priorityLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →